Tenaya Therapeutics, Inc. Common Stock

€0.68903
EUR
Last updated on --.
24h volume3.07M
24h highest0.71410 EUR
24h lowest0.67534 EUR
24h Price movement+2.29%

TNYA recent prices

24 Hours
+2.29%+€0.015419
30 days
+17.51%+€0.10423
60 days
+30.97%+€0.16539
90 days
+44.54%+€0.21552

Key data

Previous close0.67361 EUR
Market cap151.05M EUR
Volume3.07M
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-0.32733 EUR
Net income (FY)-71.50M EUR
Revenue (FY)193.82K EUR
Last report date6 May 2026

About Tenaya Therapeutics, Inc. Common Stock

BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
HeadquartersSOUTH SAN FRANCISCO
Employees (FY)70.00
Revenue per employee (FY)2.77K EUR
Net income per employee (FY)-1.02M EUR
Listed onNasdaq
Official website

TNYA conversion tables

TNYATNYA
EUREUR
0.5 TNYA0.34452 EUR
1 TNYA0.68903 EUR
5 TNYA3.445 EUR
10 TNYA6.890 EUR
EUREUR
TNYATNYA
0.5 EUR0.72565 TNYA
1 EUR1.451 TNYA
5 EUR7.256 TNYA
10 EUR14.51 TNYA

FAQ

TNYA is trading at €0.68903, +2.29% over the last 24 hours. Track live moves on the price chart at the top of this page.
The TNYA stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. TNYA is currently trading at €0.68903, +2.29% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on TNYA price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. TNYA's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from TNYA; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against TNYA's historical range and other companies in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.
Tenaya Therapeutics, Inc. Common Stock's market cap is currently 151.05M EUR. Market cap is calculated as stock price × total shares outstanding.

Disclaimer

The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.

OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume3.07M
24h highest0.71410 EUR
24h lowest0.67534 EUR
24h Price movement+2.29%
TNYATNYA
EUREUR
Start trade with TNYA Perpetual